Call Options Transactions Made in Q4 2023 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q4 2023. The information is specifically focused on institutions that hold call options of EyePoint Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
441K+ 764.47% |
$2.52M - $10.6M
|
499K
$4.01M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
396K+ 240.62% |
$2.26M - $9.56M
|
561K
$4.51M
|
|
|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
391KNew |
$2.23M - $9.43M
|
391K
$3.14M
|
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
150KNew |
$857K - $3.62M
|
150K
$1.21M
|
|
|
Feb 14, 2024
Q4 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
93.5KNew |
$534K - $2.26M
|
93.5K
$752K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
40KNew |
$228K - $965K
|
40K
$322K
|
|
|
Feb 13, 2024
Q4 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
4.4KNew |
$25.1K - $106K
|
4.4K
$35.4K
|